Sullivan James Crowley

Chief Scientific OfficerenGene Holdings Inc. (ENGN) · full profile →Form 4 · filed Nov 2, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
0 non-derivative · 2 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 7, 2023Grant(A)119K119K
Mar 18, 2022Grant(A)89K89K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000929638-23-002988) within minutes of acceptance. Every field above traces to the original document. Verify it directly: